Eaton Vance Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
Other funds holding SYNH
CB
Eaton Vance Management's SYNH Position: Q3 2022 in Review
Eaton Vance Management increased its Syneos Health, Inc. Class A Common Stock (SYNH) stake by 0.67% in Q3 2022, buying an estimated $26.2K and bringing the position to 61,133 shares worth $2.88M. The position accounts for ﹤0.01% of the portfolio, ranked #932.
Eaton Vance Management first reported a position in SYNH in Q4 2017 and has held it in 20 quarters since. The position peaked at $5.34M in Q1 2022. 337 funds tracked by Wall St. Rank hold SYNH as of Q3 2022.
- Eaton Vance Management held 61,133 shares of Syneos Health, Inc. Class A Common Stock worth $2.88M as of Q3 2022.
- Eaton Vance Management bought 406 Syneos Health, Inc. Class A Common Stock shares in Q3 2022, an estimated $26.2K.
- Syneos Health, Inc. Class A Common Stock made up ﹤0.01% of Eaton Vance Management's portfolio in Q3 2022, its #932 holding.
- Eaton Vance Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2017 and has held it in 20 quarters since.
- Eaton Vance Management's Syneos Health, Inc. Class A Common Stock position peaked at $5.34M in Q1 2022.
- 337 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2022.
Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.